Skip to main content
KimeraCHEMS
Display
  • C
  • N

Calculated reference model · not an experimental or batch-certified structure. All 14 atoms shown.

Model data & sources
  • Heavy atoms only; hydrogens are omitted from the reference display.
  • Source-defined stereochemistry is checked against the calculated coordinates; no energy-minimum, crystal or solution-structure claim is made.
  • Reference molecular species only; batch identity, purity, counterions and excipients are not certified.
Formula
C12H10N2
Method
RDKit ETKDGv3 / MMFF94s calculated reference conformer
In stock nowBrowse more certificates
Batch 1 of 2
KC-9ME-04
Batch 2 of 2
KC-9ME-05
The forms on this page come off different batches, so more than one code is shipping. Each has its own certificate, and the code printed on your label is the one you have.

9-ME-BC

Nootropics

Published formats

  • Powder 1g
  • Dry-Fill Capsule 60ct/20mg/1.2g
What is the difference between these?
Powder
Raw material as a solid. Nothing added and nothing portioned; the stated weight is what is in the container.
Dry-Fill Capsule
Capsules filled with the weighed solid. The label gives the amount in each capsule and the number in the bottle.
Each label gives the amount per unit and the total, so compare the totals rather than the container size.

Supplementary product details from the published catalog, checked 2026-10-07. These reference details do not establish current availability.

Pricing

Pricing and order placement are reserved for reviewed research accounts. Log in or submit an account application to view current product pricing.

Log in to view priceApply for account

Technical Specifications

Batch COA Database ↗
CAS Registry Number2521-07-5
Molecular FormulaC₁₂H₁₀N₂
Molecular Weight182.226 g/mol
IUPAC Designation9-methyl-9H-pyrido[3,4-b]indole
Physical FormWhite to off-white/pale brown powder
Storage RequirementsRefer to product documentation
Other Names9-MBC, 9-Methylnorharman, N-Methyl-β-carboline
Capsule Concentration20mg x 60ct
Bulk Powder Quantity1g

Identity fields from the published product record, checked 2026-10-07. Reference information is not a batch identity certificate.

Research Overview

9-ME-BC (9-Methyl-beta-carboline) Research Standard

9-ME-BC (9-Methyl-beta-carboline) is a heterocyclic amine derivative belonging to the beta-carboline family. Within the field of neuropharmacology, it is an investigative compound characterized by its potential dopaminergic and neurotrophic properties. Researchers utilize 9-ME-BC as a pharmacological probe to study pathways involved in neuroprotection, the stimulation of neurite outgrowth, and the enhancement of dopaminergic signaling in controlled in vitro and animal models.

Physical & Handling Properties

Property Specification
Physical Appearance White to off-white/pale brown powder

Mechanism of Action & Research Context

9-ME-BC is primarily investigated for its effects on the dopaminergic system and its potential neuro-regenerative influence, as detailed in established scientific literature.

  • Neurite Outgrowth and TH Expression: 9-ME-BC is notably researched for its neurotrophic properties. Foundational studies by Gille et al. (2011) demonstrated that the compound stimulates neurite outgrowth and increases the expression of tyrosine hydroxylase (TH)—the rate-limiting enzyme in dopamine synthesis—in cultured mesencephalic dopaminergic neurons.

  • Neuroprotective Mechanisms: Research into the compound's neuroprotective capacity indicates it may mitigate dopaminergic degeneration. Studies by Polanski et al. (2010) evaluated the compound's ability to provide protection against neurotoxic insults in cellular models, suggesting a role in maintaining dopaminergic neuronal integrity under stress.

  • Cognitive and Behavioral Research: Investigations into the compound's potential effects on higher-order function have utilized animal models. Research by Gille et al. (2013) observed improvements in spatial learning and memory following administration, hypothesizing that 9-ME-BC may modulate synaptic connectivity pathways.

Research Applications

9-ME-BC is a specialized reagent essential for modern neuroscience and neuro-degenerative research.

Primary fields of in vitro and laboratory investigation include:

  • Neuroprotection Studies: Assessing the ability of the compound to rescue dopaminergic neurons from neurotoxin-induced damage in cellular models.

  • Neurite Outgrowth Analysis: Quantifying the effect of 9-ME-BC on axonal and dendritic extension in cultured primary neurons.

  • Dopaminergic Signaling: Benchmarking the compound’s efficacy in modulating dopamine synthesis and turnover rates.

  • Cognitive Enhancement Models: Utilizing animal models to observe the impact of 9-ME-BC on memory, learning, and synaptic connectivity pathways.

Storage & Handling Guidelines

Store at controlled room temperature. Keep tightly closed.

Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.

Related Research Compounds

Research Use Disclaimer

Research Use Only Disclaimer: This product is labeled and sold "For Research Use Only — NOT FOR HUMAN CONSUMPTION." It is not a drug, dietary supplement, food, cosmetic, or medical device, and it is not approved by the FDA or any other regulator for human or veterinary use. It is supplied to approved account holders as a research chemical for laboratory use and must be handled in accordance with applicable law.

Certificates of Analysis

Currently shipping from batches KC-9ME-04 and KC-9ME-05. The code printed on your label says which one you have.

Related products

Kimera Chems

Compounds That Survive Scrutiny

Research use only. Not for human or veterinary use.